Peng Hairong, Usas Arvydas, Olshanski Anne, Ho Andrew M, Gearhart Brian, Cooper Gregory M, Huard Johnny
Growth and Development Laboratory, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA.
J Bone Miner Res. 2005 Nov;20(11):2017-27. doi: 10.1359/JBMR.050708. Epub 2005 Jul 18.
We studied the interaction between VEGF and BMP2 during bone formation and bone healing. Results indicate that VEGF antagonist inhibited BMP2-elicited bone formation, whereas the delivery of exogenous VEGF enhanced BMP2-induced bone formation and bone healing through modulation of angiogenesis.
Angiogenesis is closely associated with bone formation during normal bone development and is important for the bone formation elicited by BMP4. However, it remains unknown whether vascular endothelial growth factor (VEGF) also interacts with other BMPs, especially BMP2, in bone formation and bone healing.
For this study, mouse muscle-derived stem cells were transduced to express BMP2, VEGF, or VEGF antagonist (sFlt1). We studied the angiogenic process during endochondral bone formation elicited by BMP2, a prototypical osteogenic BMP. Using radiographic and histologic analyses, we also evaluated the interaction between VEGF and BMP2 during bone formation and bone healing.
Our results indicate that BMP2-elicited bone formation comprises two phases of angiogenesis, with an early phase occurring before the appearance of hypertrophic cartilage, followed by a late phase coupled with the appearance of hypertrophic cartilage. Our finding that the administration of sFlt1, a specific antagonist of VEGF, significantly inhibited BMP2-induced bone formation and the associated angiogenesis indicates that endogenous VEGF activity is important for bone formation. Furthermore, we found that the delivery of exogenous VEGF enhanced BMP2-induced bone formation and bone healing by improving angiogenesis, which in turn led to accelerated cartilage resorption and enhanced mineralized bone formation. Our findings also indicate that the ratio between VEGF and BMP2 influences their synergistic interaction, with a higher proportion of VEGF leading to decreased synergism. Our study also revealed unique VEGF-BMP2 interactions that differ from the VEGF-BMP4 interactions that we have described previously.
This study, along with previously published work, shows that VEGF interacts synergistically with both BMP4 and BMP2 but elicits substantially different effects with these two BMPs.
我们研究了血管内皮生长因子(VEGF)与骨形态发生蛋白2(BMP2)在骨形成和骨愈合过程中的相互作用。结果表明,VEGF拮抗剂抑制BMP2诱导的骨形成,而外源性VEGF的递送通过调节血管生成增强BMP2诱导的骨形成和骨愈合。
血管生成在正常骨发育过程中与骨形成密切相关,并且对于BMP4诱导的骨形成很重要。然而,血管内皮生长因子(VEGF)在骨形成和骨愈合过程中是否也与其他骨形态发生蛋白(BMPs)相互作用,尤其是与BMP2相互作用,仍然未知。
在本研究中,对小鼠肌肉来源的干细胞进行转导,使其表达BMP2、VEGF或VEGF拮抗剂(sFlt1)。我们研究了由典型的成骨BMP2诱导的软骨内骨形成过程中的血管生成过程。使用影像学和组织学分析,我们还评估了VEGF与BMP2在骨形成和骨愈合过程中的相互作用。
我们的结果表明,BMP2诱导的骨形成包括两个血管生成阶段,早期阶段发生在肥大软骨出现之前,随后是与肥大软骨出现相关的晚期阶段。我们发现给予VEGF特异性拮抗剂sFlt1可显著抑制BMP2诱导的骨形成和相关的血管生成,这表明内源性VEGF活性对骨形成很重要。此外,我们发现外源性VEGF的递送通过改善血管生成增强了BMP2诱导的骨形成和骨愈合,这反过来又导致软骨吸收加速和矿化骨形成增强。我们的研究结果还表明,VEGF与BMP2之间的比例影响它们的协同相互作用,VEGF比例越高,协同作用越低。我们的研究还揭示了独特的VEGF - BMP2相互作用,与我们之前描述的VEGF - BMP4相互作用不同。
本研究以及之前发表的工作表明,VEGF与BMP4和BMP2均具有协同相互作用,但对这两种BMPs产生的影响有很大不同。